======= TACC3 ======= == Gene Information == * **Official Symbol**: TACC3 * **Official Name**: transforming acidic coiled-coil containing protein 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10460|10460]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6A5|Q9Y6A5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TACC3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TACC3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605303|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (PubMed:21297582, PubMed:23532825). May be involved in the control of cell growth and differentiation. May contribute to cancer (PubMed:14767476). {ECO:0000250|UniProtKB:Q9JJ11, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}. |TACC| |metaphase/anaphase transition of mitotic cell cycle| |metaphase/anaphase transition of cell cycle| |regulation of mitotic spindle organization| |regulation of spindle organization| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |mitotic spindle organization| |mitotic spindle| |regulation of sister chromatid segregation| |regulation of chromosome segregation| |microtubule cytoskeleton organization involved in mitosis| |cerebral cortex development| |spindle pole| |spindle organization| |microtubule organizing center| |regulation of mitotic nuclear division| |pallium development| |regulation of microtubule cytoskeleton organization| |regulation of nuclear division| |regulation of microtubule-based process| |telencephalon development| |mitotic cell cycle phase transition| |cell cycle phase transition| |regulation of chromosome organization| |forebrain development| |microtubule cytoskeleton organization| |cell division| |regulation of cytoskeleton organization| |cell population proliferation| |mitotic cell cycle process| |regulation of mitotic cell cycle| |microtubule-based process| |mitotic cell cycle| |brain development| |regulation of cell cycle process| |head development| |central nervous system development| |cell cycle process| |cytoskeleton organization| |regulation of cell cycle| |regulation of organelle organization| |cell cycle| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-4.25| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-3.81| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-3.48| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-3.48| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-3.4| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-3.25| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-2.96| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.93| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.91| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|-2.83| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.61| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-2.58| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-2.5| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.5| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.41| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-2.38| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.32| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-2.28| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.27| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.19| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-2.13| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-2.11| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.99| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-1.98| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.89| ^Gene^Correlation^ |[[:human genes:d:dlgap5|DLGAP5]]|0.75| |[[:human genes:g:gak|GAK]]|0.648| |[[:human genes:g:gtse1|GTSE1]]|0.582| |[[:human genes:a:aspm|ASPM]]|0.537| |[[:human genes:k:kif15|KIF15]]|0.531| |[[:human genes:g:gsg2|GSG2]]|0.531| |[[:human genes:c:cdca2|CDCA2]]|0.52| |[[:human genes:s:sephs1|SEPHS1]]|0.501| |[[:human genes:e:esco2|ESCO2]]|0.487| |[[:human genes:m:mapre1|MAPRE1]]|0.476| |[[:human genes:c:calm2|CALM2]]|0.457| |[[:human genes:k:klf16|KLF16]]|0.448| |[[:human genes:u:ube4b|UBE4B]]|0.417| |[[:human genes:c:cltc|CLTC]]|0.414| |[[:human genes:b:brap|BRAP]]|0.408| Global Fraction of Cell Lines Where Essential: 77/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|3/28| |blood|0/28| |bone|2/26| |breast|3/33| |central nervous system|6/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|2/16| |kidney|2/21| |liver|1/20| |lung|6/75| |lymphocyte|2/16| |ovary|6/26| |pancreas|3/24| |peripheral nervous system|2/16| |plasma cell|0/15| |prostate|1/1| |skin|2/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|9/22| |urinary tract|4/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2778 * **Expression level (log2 read counts)**: 8.17 {{:chemogenomics:nalm6 dist.png?nolink |}}